Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Mesut, Eren"'
Autor:
T. Mesut Eren
Publikováno v:
Ankara Avrupa Çalışmaları Dergisi, Vol 23, Iss 1, Pp 101-127 (2024)
In this article, the Association Agreements of Greece, which signed the first association agreement with the European Economic Community (EEC), and then Türkiye, which signed a similar agreement, were compared. It has been argued for a long time tha
Externí odkaz:
https://doaj.org/article/427ae07ffd64438abf51cebd523ba45b
Autor:
Joshua A. Levine, Carlota Oleaga, Mesut Eren, Ansel P. Amaral, Meng Shang, Elizabeth Lux, Sadiya S. Khan, Sanjiv J. Shah, Yasuhiro Omura, Nathalie Pamir, Joshua Hay, Grant Barish, Toshio Miyata, Hagai Tavori, Sergio Fazio, Douglas E. Vaughan
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Plasminogen activator inhibitor 1 (PAI-1) is a functional biomarker of the metabolic syndrome. Previous studies have demonstrated that PAI-1 is a mechanistic contributor to several elements of the syndrome, including obesity, hypertension an
Externí odkaz:
https://doaj.org/article/70f544abac804254b08f94ba760c8b5e
Publikováno v:
Journal of Productivity Analysis. 59:287-306
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a89f59b06f98a3c760accfc7d21b11e
https://doi.org/10.1007/s11123-023-00668-1
https://doi.org/10.1007/s11123-023-00668-1
Autor:
Rahul Rai, Asish K. Ghosh, Mesut Eren, Alexander R. Mackie, Daniel C. Levine, So-Youn Kim, Jonathan Cedernaes, Veronica Ramirez, Daniele Procissi, Layton H. Smith, Teresa K. Woodruff, Joseph Bass, Douglas E. Vaughan
Publikováno v:
Cell Reports, Vol 21, Iss 6, Pp 1471-1480 (2017)
Summary: Aging drives the occurrence of numerous diseases, including cardiovascular disease (CVD). Recent studies indicate that blood from young mice reduces age-associated pathologies. However, the “anti-aging” factors in juvenile circulation re
Externí odkaz:
https://doaj.org/article/e57763e528694b2495fe9be8e1900ad1
Publikováno v:
Journal of Coatings Technology and Research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0c915a3297f3b18503cb6491db6dd34
https://doi.org/10.1007/s11998-023-00767-6
https://doi.org/10.1007/s11998-023-00767-6
Autor:
Asish K, Ghosh, Anthony A, Kalousdian, Meng, Shang, Elizabeth, Lux, Mesut, Eren, Anna, Keating, Lisa D, Wilsbacher, Douglas E, Vaughan
Publikováno v:
Cellular Signalling. 104:110555
Plasminogen activator inhibitor-1 (PAI-1) is a specific and rapid-acting inhibitor of endogenous plasminogen activators (uPA and tPA). The global PAI-1 knockout mice (PAI-1KO) develop age-dependent cardiac-selective fibrosis, and young global PAI-1KO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::110dc2f84a91b0d901a5cd2e488a6be0
https://doi.org/10.1016/j.cellsig.2022.110555
https://doi.org/10.1016/j.cellsig.2022.110555
Autor:
Bora Çoşkun, Bugra Coskun, Mesut Eren, Esra Uçaryılmaz Özhamam, Cihangir M. Ercan, Douglas E. Vaughan, Cihan Togrul
Publikováno v:
Reproductive BioMedicine Online. 42:16-25
Research question: Angiotensin-converting enzyme inhibition results in a significant reduction in plasma concentrations of plasminogen activator inhibitor-1 (PAI-1). What are the effects of lisinopril treatment on PAI-1 concentrations and the morphol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c315798ea85f3ee9060043829c870fd4
https://doi.org/10.1016/j.rbmo.2020.09.011
https://doi.org/10.1016/j.rbmo.2020.09.011
Autor:
Yasuhiro Omura, Joshua A. Levine, Joshua Hay, Carlota Oleaga, Toshio Miyata, Nathalie Pamir, Grant D. Barish, Sanjiv J. Shah, Douglas E. Vaughan, Hagai Tavori, Sergio Fazio, Mesut Eren, Elizabeth Lux, Sadiya S. Khan, Ansel Philip Amaral, Meng Shang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Scientific Reports
Scientific Reports
Plasminogen activator inhibitor 1 (PAI-1) is a functional biomarker of the metabolic syndrome. Previous studies have demonstrated that PAI-1 is a mechanistic contributor to several elements of the syndrome, including obesity, hypertension and insulin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c4e413468076d341f5da388738adab0
https://doaj.org/article/70f544abac804254b08f94ba760c8b5e
https://doaj.org/article/70f544abac804254b08f94ba760c8b5e
Autor:
Lacy M Simons, Ramon Lorenzo-Redondo, Meg Gibson, Sarah L Kinch, Jacob P Vandervaart, Nina L Reiser, Mesut Eren, Elizabeth Lux, Elizabeth M McNally, Anat R Tambur, Douglas E Vaughan, Kelly E R Bachta, Alexis R Demonbreun, Karla J F Satchell, Chad J Achenbach, Egon A Ozer, Michael G Ison, Judd F Hultquist
Publikováno v:
Open forum infectious diseases. 9(3)
Background While several demographic and clinical correlates of coronavirus disease 2019 (COVID-19) outcome have been identified, their relationship to virological and immunological parameters remains poorly defined. Methods To address this, we perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd118c851db6eb46ebb4d8164c21858b
https://pubmed.ncbi.nlm.nih.gov/35198645
https://pubmed.ncbi.nlm.nih.gov/35198645
Autor:
Amanda E Boe, Mesut Eren, Luisa Morales-Nebreda, Sheila B Murphy, G R Scott Budinger, Gökhan M Mutlu, Toshio Miyata, Douglas E Vaughan
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0116504 (2015)
Nω-nitro-L-arginine methyl ester (L-NAME) treatment induces arteriosclerosis and vascular senescence. Here, we report that the systemic inhibition of nitric oxide (NO) production by L-NAME causes pulmonary emphysema. L-NAME-treated lungs exhibited b
Externí odkaz:
https://doaj.org/article/1b1a764187d84af89105945562e912f4